Human papillomavirus type 5 E6 oncoprotein represses the transforming growth factor beta signaling pathway by binding to SMAD3.
Mechanisms of cellular transformation associated with human papillomavirus type 5 (HPV5), which is responsible for skin carcinomas in epidermodysplasia verruciformis (EV) patients, are poorly understood. Using a yeast two-hybrid screening and molecular and cellular biology experiments, we found that HPV5 oncoprotein E6 interacts with SMAD3, a key component in the ... transforming growth factor beta1 (TGF-beta1) signaling pathway. HPV5 E6 inhibits SMAD3 transactivation by destabilizing the SMAD3/SMAD4 complex and inducing the degradation of both proteins. Interestingly, the E6 protein of nononcogenic EV HPV9 failed to interact with SMAD3, suggesting that downregulation of the TGF-beta1 signaling pathway could be a determinant in HPV5 skin carcinogenesis.
Mesh Terms:
Alphapapillomavirus, Down-Regulation, Humans, Oncogene Proteins, Viral, Signal Transduction, Smad3 Protein, Transforming Growth Factor beta, Two-Hybrid System Techniques
Alphapapillomavirus, Down-Regulation, Humans, Oncogene Proteins, Viral, Signal Transduction, Smad3 Protein, Transforming Growth Factor beta, Two-Hybrid System Techniques
J Virol
Date: Dec. 01, 2006
PubMed ID: 17020941
View in: Pubmed Google Scholar
Download Curated Data For This Publication
254728
Switch View:
- Interactions 5